Cannabis

Does Cannabis Increase Serotonin? Mood, Brain Chemistry, and Risks

Lead Psychologist

Sep 7, 2025

Does cannabis increase serotonin, or is the story more complex? Many people believe marijuana works like an antidepressant, directly boosting this “feel-good” neurotransmitter. But research shows cannabis doesn’t actually raise serotonin levels—it modulates how serotonin neurones fire and how receptors respond, mainly through CB1 receptor pathways in the brain’s dorsal raphe nuclei.1


This article explores the science behind cannabis and serotonin, the differences between THC and CBD, and what this means for mood, anxiety, depression, and safe use.


Key Takeaways

  • Cannabis does not directly increase serotonin levels; it influences serotonin signalling and receptor activity.

  • CBD may improve mood through 5-HT1A receptor activation, while THC alters serotonin circuits indirectly.

  • Feeling calmer or happier after cannabis doesn’t prove serotonin elevation—multiple neurotransmitters are involved.

  • Cannabis can interact with antidepressants and, in rare cases, contribute to serotonin syndrome.

  • Harm reduction includes low dosing, avoiding risky drug combinations, and monitoring mood effects over time.
    The key question isn’t “Does cannabis increase serotonin?” but how cannabis changes serotonin pathways that regulate mood.


CBD’s Antidepressant-Like Effects Work Through Serotonin Receptors (Not More Serotonin)

Cannabidiol (CBD) is often promoted as a natural antidepressant, but its effects are more subtle than a direct serotonin boost. Research shows CBD interacts with the 5-HT1A receptor, a serotonin receptor subtype closely linked to mood and anxiety regulation.2

In animal studies, CBD produced rapid antidepressant-like effects by enhancing how serotonin signals are transmitted in the brain. Importantly, this wasn’t because CBD increased serotonin production—it made the brain’s existing serotonin system work more efficiently.

This mechanism explains why many people report calmer moods or reduced anxiety with CBD, even though their overall serotonin levels remain unchanged. Instead of flooding the brain with serotonin, CBD fine-tunes the way serotonin receptors respond, creating a more balanced neurochemical environment.

For individuals struggling with depression or anxiety, this suggests CBD may act more like a serotonin signal enhancer than a serotonin “booster”.


How Cannabis Can Also Suppress Serotonin Release

While CBD may enhance serotonin signalling in certain pathways, cannabis is not uniformly serotonin-friendly. Evidence shows that activation of CB1 receptors—especially by THC—can actually reduce serotonin release in parts of the brain, including the frontal cortex.3

This suppression means cannabis can sometimes dampen mood regulation circuits instead of enhancing them. For some people, this may contribute to feelings of apathy, low motivation, or even increased anxiety after cannabis use.

These findings highlight why the effects of cannabis on mood are so mixed:

  • CBD often promotes anxiolytic and antidepressant effects by modulating serotonin receptors.

  • THC, through CB1 activation, may blunt serotonin release, producing either relaxation or worsening anxiety, depending on the user and context.


In short, cannabis doesn’t have a one-size-fits-all effect on serotonin. Its impact depends on dose, cannabinoid composition, and individual brain chemistry.


Cross-Talk Between Cannabis and Serotonin Receptors

Another way cannabis influences mood is through receptor cross-talk—the way different receptor systems interact with each other. Research has found that cannabinoids can enhance interactions between serotonin 5-HT2A receptors and dopamine D2 receptors in the prefrontal cortex.4

This means cannabis doesn’t necessarily raise serotonin levels but can change how serotonin and dopamine systems communicate. Since both neurotransmitters are central to mood, motivation, and perception, this receptor-level interaction may help explain why cannabis produces a wide range of psychological effects.

For some, this cross-talk could feel uplifting or stabilizing. For others, particularly at higher doses, it might contribute to mood swings, anxiety, or perceptual changes. This receptor interplay underscores why cannabis is not simply “pro-serotonin” but instead a complex neuromodulator.


Cannabis, Serotonin Receptors, and Anxiety Risk

Cannabis doesn't just influence serotonin signalling—it can also change the density of serotonin receptors in the brain. Chronic cannabinoid exposure has been shown to upregulate 5-HT2A receptors in the hypothalamus.5

This receptor increase is linked to anxiety-like behaviors in animal studies. In practical terms, this means that long-term or heavy cannabis use could heighten sensitivity to serotonin signaling in ways that actually make anxiety worse, especially in individuals predisposed to mood disorders.

These findings align with clinical observations: while some users experience relaxation or calm with cannabis, others report paranoia, restlessness, or heightened stress. The difference may depend on how a person’s serotonin receptors adapt to repeated cannabis exposure.

In short, cannabis doesn’t reliably increase serotonin—it can reshape serotonin receptor networks, sometimes leading to unexpected mood outcomes.


CBD and the Serotonin System — A Closer Look at the Mechanisms

CBD’s antidepressant-like effects have gained scientific attention because they operate through receptor-level mechanisms rather than direct serotonin elevation. A comprehensive review found that CBD’s benefits are primarily linked to 5-HT1A receptor activation.6

This receptor is often called the brain’s “calming switch” because it helps regulate mood, stress, and anxiety. By binding to 5-HT1A, CBD can mimic serotonin’s natural effects, enhancing signalling efficiency without raising serotonin levels themselves.

This indicates that CBD may support mental health in the following ways:

  • Reducing anxiety through enhanced 5-HT1A signaling

  • Promoting resilience against stress-related mood disorders

  • Offering antidepressant-like effects without directly altering serotonin production

These insights reinforce that CBD works more like a signal amplifier than a serotonin booster, fine-tuning existing neurotransmitter systems for better balance.


Antidepressant Effects of CBD Depend on Serotonin Receptors

Animal studies provide even stronger evidence that CBD’s mood benefits hinge on serotonin receptor activity. In one experiment, the antidepressant-like effects of CBD disappeared when 5-HT1A receptors were blocked with an antagonist.7

This confirms that CBD doesn’t raise serotonin levels directly—it works by engaging serotonin receptors to produce mood-regulating effects. Without receptor activity, CBD loses its therapeutic impact.

For mental health, this suggests CBD’s value lies in its ability to activate existing serotonin pathways, not in creating new serotonin. It also means people with disrupted serotonin receptor function (such as in certain mood disorders) may respond differently to CBD than those with intact receptor signaling.


THC, Neurogenesis, and Indirect Effects on Mood

Not all THC effects on the brain are negative. Some studies suggest that THC may support neurogenesis—the growth of new brain cells—and influence cognition through complex neurotransmitter interactions. In one experiment, acute THC exposure improved certain aspects of cognitive performance in rats, though not by directly increasing serotonin<sup>9</sup>.

Instead, THC appears to modulate multiple systems at once, including dopamine, glutamate, and serotonin circuits. This layered effect may explain why some users feel sharper or more creative after cannabis, while others feel foggy or anxious.

To clarify, here’s a table comparing how CBD and THC affect serotonin-related brain function:


Table 1. Differences Between CBD and THC in Serotonin Modulation

Feature

CBD

THC

Direct serotonin increase?

No

No

Key mechanism

Activates 5-HT1A receptors (signal enhancer)

Activates CB1 receptors (can inhibit serotonin release)

Mood effect

Often calming, antidepressant-like

Relaxation at low doses, anxiety or mood disruption at high doses

Impact on receptors

Improves signaling efficiency

May reduce serotonergic activity with chronic use

Mental health implications

Potential therapy for anxiety/depression

Risk of worsened mood with long-term heavy use


Cannabis and Depression — What Clinical Studies Show

Beyond lab and animal models, clinical studies help reveal how cannabis affects mood in real-world settings. A large observational study covering nearly 6,000 cannabis use sessions found that cannabis flower provided immediate relief from depression symptoms for many participants.10

Interestingly, this rapid mood lift did not necessarily indicate a serotonin increase. Researchers suggested that cannabis likely improves mood through receptor modulation, dopamine-glutamate interactions, or stress relief, rather than directly boosting serotonin levels.

This aligns with reports from patients who use medical marijuana for depression: while some feel better quickly, others experience no change—or even worsening mood depending on strain, dose, and individual brain chemistry.


Medical Cannabis in Mental Health Disorders — Limited Serotonin Evidence

With the rise of medical marijuana, many patients seek it for relief from anxiety, depression, or mood instability. But systematic reviews show that the serotonin story is far less clear. A clinically focused review concluded that while cannabis may offer short-term symptom relief, direct serotonin-related mechanisms remain poorly supported in psychiatric disorders.11

Therefore, it's unlikely that higher serotonin levels, even when people report improved mood, are the cause. Instead, the effects probably come from receptor-level modulation, dopamine interactions, or stress-related pathways.

To highlight the gap between belief and evidence, here’s a comparison:


Table 2. Cannabis and Serotonin — Myth vs. Science

Popular Belief

What Science Shows

Cannabis raises serotonin like antidepressants.

Cannabis does not increase serotonin levels; it alters receptor signalling instead.

Feeling better after using cannabis does not necessarily prove that serotonin levels have elevated.

Mood changes stem from CB1/CB2, dopamine, and 5-HT1A receptor effects, not higher serotonin.

Cannabis works as a serotonin-based antidepressant.

Evidence suggests short-term symptom relief but no consistent serotonin-driven mechanism.

Long-term use keeps serotonin elevated.

Chronic THC may suppress serotonin activity and upregulate 5-HT2A receptors, sometimes worsening mood.


How Cannabis May Influence Serotonin Through Tryptophan Metabolism

Serotonin production begins with tryptophan, an amino acid obtained from diet. Interestingly, cannabinoids may influence serotonin indirectly by altering tryptophan metabolism pathways. Research suggests that cannabis compounds can shift immune and metabolic processes that affect how much tryptophan is available for conversion into serotonin.12

However, this doesn’t mean cannabis directly increases serotonin synthesis. Instead, the effect is secondary, shaped by cannabis’s influence on inflammation and immune function. For example, by lowering certain inflammatory signals, cannabinoids could make more tryptophan available for serotonin production—but this remains a theoretical pathway, not a proven clinical effect.

In practice, the serotonin changes from this mechanism are likely subtle and variable between individuals, making it a less reliable explanation for cannabis’s mood effects.


Tolerance and Why Serotonin Isn’t the Whole Story

If cannabis truly worked by directly raising serotonin levels, its mood effects should be consistent over time. But studies show the opposite: with regular use, people often develop tolerance, meaning the same dose produces weaker effects.

A systematic review of human evidence found that cannabis users develop tolerance across many brain systems, including mood and reward pathways.13 This suggests cannabis is not sustaining elevated serotonin levels—if it did, tolerance would not blunt its effects so predictably.

Instead, tolerance likely reflects the brain adapting to repeated receptor activation, particularly at CB1. This adaptation further supports the conclusion that cannabis alters serotonin signalling efficiency and receptor sensitivity, not serotonin production.


Cannabis, Serotonin Syndrome, and Antidepressant Interactions

One of the primary concerns around cannabis and serotonin is its potential interaction with antidepressant medications. While cannabis does not increase serotonin directly, it can still affect serotonin receptors and other neurotransmitter systems.

A recent clinical review emphasised the need to exercise caution when patients combine cannabis with SSRIs, SNRIs, or MAOIs. The concern is not additive serotonin elevation but rather complex receptor interactions that could increase the risk of serotonin syndrome in rare cases.14

Serotonin syndrome occurs when serotonin signalling becomes dangerously overactive, leading to agitation, rapid heart rate, tremors, or even life-threatening complications. While rare, patients on serotonergic medications should approach cannabis use cautiously and consult their prescribing doctor before combining therapies.


The Big Picture — Cannabis and Serotonin in Context

When all the evidence is reviewed together, the conclusion becomes clear: cannabis does not act as a serotonin booster. A large pharmacology-based systematic review and meta-analysis found no consistent evidence that cannabis directly increases serotonin levels.15

Instead, cannabis exerts its mood effects through:

  • Receptor modulation — CBD activating 5-HT1A, THC acting on CB1

  • Neural cross-talk — interactions between serotonin, dopamine, and glutamate systems

  • Neuroplasticity — long-term changes in brain signaling pathways

  • Tolerance development — gradual blunting of effects with repeated use

This theory helps explain why cannabis can feel like an antidepressant to some, while others experience anxiety, brain fog, or no benefit at all. The effects are indirect, receptor-driven, and highly individual—not the result of a serotonin surge.


Frequently Asked Questions


1. Does cannabis increase serotonin levels in the brain?

No. Research shows cannabis does not directly raise serotonin levels. Instead, it modifies serotonin receptors and signalling pathways.


2. Why do people feel happier or calmer after cannabis if serotonin isn’t increased?

Mood changes come from receptor modulation (CBD at 5-HT1A) and interactions with dopamine and glutamate, not from serotonin production.


3. Can CBD help with depression or anxiety through serotonin?

Yes, but indirectly. CBD's antidepressant-like effects depend on 5-HT1A receptor activation, which enhances serotonin signalling without boosting levels.


4. Does THC affect serotonin differently than CBD?

Yes. THC primarily activates CB1 receptors, which can suppress serotonin release and, with chronic use, lower serotonergic activity.


5. Can cannabis cause serotonin syndrome if taken with antidepressants?

It’s rare, but possible. Cannabis may increase serotonin receptor activity when combined with SSRIs, SNRIs, or MAOIs, raising the risk of serotonin syndrome in sensitive individuals.


6. Is medical cannabis a safe alternative to antidepressants?

Not necessarily. While cannabis may relieve symptoms for some, systematic reviews find little direct evidence of serotonin-driven benefits. Medical use should be guided by a professional.


Conclusion: Does Cannabis Increase Serotonin?

So, does cannabis increase serotonin? The evidence says no—at least not directly. Cannabis does not function like SSRIs or other antidepressants that raise serotonin availability. Instead, it modulates receptor systems: CBD engages 5-HT1A to enhance signalling, while THC influences CB1 and can suppress serotonin release.

The result is a complex picture:

  • For some, cannabis feels calming or mood-lifting.

  • For others, especially with chronic THC use, it may worsen anxiety or blunt mood regulation.

  • Tolerance and receptor changes mean effects often shift over time.

The bottom line: cannabis is not a serotonin booster but a neuromodulator that reshapes how serotonin pathways work. Anyone considering cannabis for mental health should do so cautiously, ideally under professional guidance, and focus on harm reduction strategies—starting low, avoiding risky combinations, and monitoring mood closely.


References

  1. Haj-Dahmane S, Shen RY. Modulation of the serotonin system by endocannabinoid signaling. Neuropharmacology. 2011 Sep;61(3):414-20. doi: 10.1016/j.neuropharm.2011.02.016. Epub 2011 Feb 24. PMID: 21354188; PMCID: PMC3110547.

  2. Linge R, Jiménez-Sánchez L, Campa L, Pilar-Cuéllar F, Vidal R, Pazos A, Adell A, Díaz Á. Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: role of 5-HT1A receptors. Neuropharmacology. 2016 Apr;103:16-26. doi: 10.1016/j.neuropharm.2015.12.017. Epub 2015 Dec 19. PMID: 26711860.

  3. Ferreira SG, Teixeira FM, Garção P, Agostinho P, Ledent C, Cortes L, Mackie K, Köfalvi A. Presynaptic CB(1) cannabinoid receptors control frontocortical serotonin and glutamate release--species differences. Neurochem Int. 2012 Jul;61(2):219-26. doi: 10.1016/j.neuint.2012.05.009. Epub 2012 May 17. PMID: 22609378; PMCID: PMC3408788.

  4. Martínez-Aguirre C, Carmona-Cruz F, Velasco AL, Velasco F, Aguado-Carrillo G, Cuéllar-Herrera M, Rocha L. Cannabidiol Acts at 5-HT1A Receptors in the Human Brain: Relevance for Treating Temporal Lobe Epilepsy. Front Behav Neurosci. 2020 Dec 15;14:611278. doi: 10.3389/fnbeh.2020.611278. PMID: 33384591; PMCID: PMC7770178.

  5. Franklin JM, Mathew M, Carrasco GA. Cannabinoid-induced upregulation of serotonin 2A receptors in the hypothalamic paraventricular nucleus and anxiety-like behaviors in rats. Neurosci Lett. 2013 Aug 26;548:165-9. doi: 10.1016/j.neulet.2013.05.039. Epub 2013 May 27. PMID: 23721787; PMCID: PMC3735609.

  6. Silote GP, Sartim A, Sales A, Eskelund A, Guimarães FS, Wegener G, Joca S. Emerging evidence for the antidepressant effect of cannabidiol and the underlying molecular mechanisms. J Chem Neuroanat. 2019 Jul;98:104-116. doi: 10.1016/j.jchemneu.2019.04.006. Epub 2019 Apr 27. PMID: 31039391.

  7. Zanelati TV, Biojone C, Moreira FA, Guimarães FS, Joca SR. Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors. Br J Pharmacol. 2010 Jan;159(1):122-8. doi: 10.1111/j.1476-5381.2009.00521.x. Epub 2009 Dec 4. PMID: 20002102; PMCID: PMC2823358.

  8. De Gregorio D, Dean Conway J, Canul ML, Posa L, Bambico FR, Gobbi G. Effects of chronic exposure to low doses of Δ9- tetrahydrocannabinol in adolescence and adulthood on serotonin/norepinephrine neurotransmission and emotional behaviors. Int J Neuropsychopharmacol. 2020 Jul 29;23(11):751–61. doi: 10.1093/ijnp/pyaa058. Epub ahead of print. PMID: 32725198; PMCID: PMC7745253.

  9. Suliman NA, Taib CNM, Moklas MAM, Basir R. Delta-9-Tetrahydrocannabinol (∆9-THC) Induce Neurogenesis and Improve Cognitive Performances of Male Sprague Dawley Rats. Neurotox Res. 2018 Feb;33(2):402-411. doi: 10.1007/s12640-017-9806-x. Epub 2017 Sep 21. PMID: 28933048; PMCID: PMC5766723.

  10. Li X, Diviant JP, Stith SS, Brockelman F, Keeling K, Hall B, Vigil JM. The Effectiveness of Cannabis Flower for Immediate Relief from Symptoms of Depression. Yale J Biol Med. 2020 Jun 29;93(2):251-264. PMID: 32607086; PMCID: PMC7309674.

  11. Sarris J, Sinclair J, Karamacoska D, Davidson M, Firth J. Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review. BMC Psychiatry. 2020 Jan 16;20(1):24. doi: 10.1186/s12888-019-2409-8. PMID: 31948424; PMCID: PMC6966847.

  12. Jenny M, Schröcksnadel S, Überall F, Fuchs D. The Potential Role of Cannabinoids in Modulating Serotonergic Signaling by Their Influence on Tryptophan Metabolism. Pharmaceuticals (Basel). 2010 Aug 13;3(8):2647-2660. doi: 10.3390/ph3082647. PMID: 27713369; PMCID: PMC4033942.

  13. Colizzi M, Bhattacharyya S. Cannabis use and the development of tolerance: a systematic review of human evidence. Neurosci Biobehav Rev. 2018 Oct;93:1-25. doi: 10.1016/j.neubiorev.2018.07.014. Epub 2018 Jul 26. PMID: 30056176.

  14. Botsford SL, Yang S, George TP. Cannabis and Cannabinoids in Mood and Anxiety Disorders: Impact on Illness Onset and Course, and Assessment of Therapeutic Potential. Focus (Am Psychiatr Publ). 2025 Apr;23(2):239-256. doi: 10.1176/appi.focus.25023010. Epub 2025 Apr 15. PMID: 40235611; PMCID: PMC11995907.

  15. Bilbao A, Spanagel R. Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications. BMC Med. 2022 Aug 19;20(1):259. doi: 10.1186/s12916-022-02459-1. PMID: 35982439; PMCID: PMC9389720.

Start rewiring
your brain today

Sunflower helps you rewire your brain to associate sobriety with reward. We combine Visual Progression Tracking, Cognitive Behavior Therapy, and an AI Sponsor to help you overcome addiction.

Start rewiring
your brain today

Sunflower helps you rewire your brain to associate sobriety with reward. We combine Visual Progression Tracking, Cognitive Behavior Therapy, and an AI Sponsor to help you overcome addiction.

Start rewiring
your brain today

Sunflower helps you rewire your brain to associate sobriety with reward. We combine Visual Progression Tracking, Cognitive Behavior Therapy, and an AI Sponsor to help you overcome addiction.

Copyright © 2025 Sunflower Limited. All rights reserved.

Copyright © 2025 Sunflower Limited. All rights reserved.

Copyright © 2025 Sunflower Limited. All rights reserved.